Showing results (1651-1660 of 1,800) with videos related to

Sort By:
Pageof 180
Arthritis Care & Research|August 29, 2015
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension StudyD J Wallace, K Hobbs, M E B Clowse, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement in United StatesHafiz M Imran, Phinnara Has, Nicholas Kassis, et al.
Trials|March 11, 2026
Views on consent approaches used in emergency and critical care research: a rapid, systematic reviewNiamh Mahon, Leanne M C Hays, Eva Coy, et al.
Journal of Hepatology|March 4, 2015
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infectionEdward J Gane, Young-Suk Lim, Stuart C Gordon, et al.
Pathogens & Immunity|September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody ResponseMarc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
Critical Care (London, England)|June 22, 2013
Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrineSangeeta Mehta, John Granton, Anthony C Gordon, et al.
Journal of Hepatology|March 20, 2018
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosisMassimo Puoti, Graham R Foster, Stanley Wang, et al.
JAMA|October 25, 2023
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical TrialTony Whitehouse, Anower Hossain, Gavin D Perkins, et al.
Thorax|March 12, 2024
Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypesDavid Benjamin Antcliffe, Yuxin Mi, Shalini Santhakumaran, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2018
Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17)Benjamin E Blass, Pravin Iyer, Magid Abou-Gharbia, et al.
Pageof 180